chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On the second vaccine I got stiff hands; when I got really sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Dose 1, Unknown Manufacturer), for COVID-19 Immunization. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious), outcome "unknown", described as "On the second vaccine I got stiff hands"; ILLNESS (non-serious), outcome "unknown", described as "when I got really sick". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: There were no prior vaccinations within 4 weeks.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Reported that approximately 15 mins after taking the vaccine she started to have have facial flushing t, rapid heart rate, redness on upper chest, and difficulty swallowing,  She was taken to the ED and observed and given benreayl whoch releved the symptoms after 1 1/2 hours.
Received Pfizer vaccines on  1/22, 2/12, 8/27/21 COVID-19 positive by PCR on 1/5/22 Admitted to hospital on 1/6/22 w/ acute renal failure; found to have Campylobacter infection
I have had increased perspiration and constant itch/irritation under both of my armpits.
This is a 35y.o. G4P2103 at 27w1d who presents to L&D triage with CC of nausea and vomiting.  Pt states that she started having N/V last Thursday after eating a meal. The patient was seen at facility on Sunday for this issue and was discharged home. She states that she has not been able to keep anything down since Sunday. She states that she has been vomiting every 1-2 hours. She endorses abdominal pain and cramping. She states that this pain happens right before an episode of vomiting and improves with vomiting. She denies any diarrhea. She has not been able to drink water due to vomiting. The nurse noted that the patients vomit is dark in color and foul smelling. No metallic smell noted upon observation of vomit. She denies any headache, congestion, or cough. (Denies) contractions, (Denies) vaginal bleeding, (Denies) loss of fluid, (Denies) decreased fetal movement.   Pregnancy is complicated by Hx of PTD @ 25w2d, COVID during pregnancy, Obesity, Hx of gastric bypass, Rh neg, HSV2, GBS bacteruria, AMA, hx PPD The patient was transitioned to PO zofran and she will be discharged with a Rx for these medications including PR Phenergan and Ensure. Pt received Makena, Rhogam, and influenza vaccination while inpatient. Pt was discharged home on HD#4 and was instructed to follow up with her primary OBGYN within a week. All questions were answered before discharge.
Starting about 11-12 hrs after receiving the vaccination I developed a fever, fatigue, headache, nausea, diarrhea, & my entire body ached. This lasted about 24 hours.
Fever Headache Body aches sore arm Chills Fatigue muscle pain Side effects went away after one day felt back to normal after 2 days of the onset of the side effects
Information has been received from a registered nurse concerning an approximately 5 month old male who "2 weeks ago", on approximately 25-SEP-2007, received his second dose early, only 2 weeks after the first dose of RotaTeq vaccine (lot# 656384/0237U). No adverse reactions were reported. A product quality complaint was not reported. No further information was available. Additional information has been requested.
This report was received from the investigator on 30 June 2010. A 35 year-old male subject with no reported medical history received the following vaccines on 13 August 2009: ACAM2000 (lot number not reported); and Hepatitis B (manufacturer and lot number not reported). On 28 August 2009, 15 days post-vaccination, the subject was diagnosed with unspecified congestive heart failure. An ECG performed 27 August 2009 was normal; Troponin I was not performed. The outcome was not reported. Additional information will be requested from the investigator. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study.
The patient experienced nausea, fever, and pain around the injection sites the day after the immunization on 09/29/2018. On 9/30/2018, the patient came to the pharmacy and presented with redness/rash around the arm. She stated that the nausea and fever have subsided but she was still in pain although not as severe. I followed up with the patient on 10/1/2018 and she states that she is no longer in pain but the rash seems to have spread. She contacted her doctor and he recommended she try BENADRYL and to contact him if the rash doesn't improve so she can be seen (she send a picture of the rash to her doctor).
The patient received a dose of the vaccine following temperature excursions on unknown dates; No adverse event; This spontaneous report as received from a medical assistant refers to a current 1-year-old patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant medications were not provided.   On an unknown date, the vaccines hepatitis a vaccine, inactivated(VAQTA) (lot # S019435 with expiration date 23-AUG-2020, lot # S026003 with expiration date 17-OCT-2020, and lot # S032056 with expiration date 09-NOV-2020) underwent a temperature excursion.   Temperature Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) Time frame 7 hours 30 minutes Previous temperature excursion? yes, Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) for 8 hours 30 minutes Was call because of a "data logger"? yes  On an unknown date, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) 25/0.5 dosage form at a dose of 0.5 ml (route not provided) for prophylaxis. No adverse events were reported.  This is one of several cases from the same reporter.  combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; manufactureraddress: ; manufacturercity: ; manufacturerstate: ; manufacturercountry:; devicelotnumber: S019435; expirationdate: 23-AUG-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent; Sender's Comments:  US-009507513-2005USA003382: US-009507513-2005USA004521: US-009507513-2005USA004522: US-009507513-2005USA004523: US-009507513-2005USA004524: US-009507513-2005USA004525: US-009507513-2005USA004526: US-009507513-2005USA004527: US-009507513-2005USA004528: US-009507513-2005USA004529: US-009507513-2005USA004530: US-009507513-2005USA004531: US-009507513-2005USA004533: US-009507513-2005USA004534: US-009507513-2005USA004535: US-009507513-2005USA004536:
Facial twitching; facial muscle weirdness; her heart was kind of fast like anxious and nervous; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EL0140, via an unspecified route of administration on left arm from 22Dec2020 to 22Dec2020 as single dose for COVID-19 immunization. The patient has no medical history. Concomitant medication included ethinylestradiol, norgestimate (SPRINTEC) as Birth control pill. OnDec2020, the patient experienced some facial twitching just like a little bit. Her facial muscle felt like a little weird and stated she does not know if it was just from getting the vaccine or what not, but couple of hours after her heart was kind of fast like anxious and nervous, that lasted for couple hours. She stated it was nothing like super outrageous, that thing stopped. But the facial muscle weirdness is kind of, her face doesn't look weird, it just like feels a little different or weird and so she was calling to report. The patient stated she don't know if you guys advise whether to get the next one if she had the reaction. When asked for treatment, she stated, "No, I haven't done anything for that." The outcome of the event heart was kind of fast like anxious and nervous was recovered on Dec2020; while the other event was not recovered.
About 3 weeks after receiving my 5th dose of the Pfizer Bivalent vaccine, I started to experience symptoms of the COVID-19 virus. This virus hit my entire household and we are all vaccinated and boosted. I originally tested negative for the COVID-19 test and my doctor told me that it was probably showing negative due to recently receiving the bivalent vaccine. A few days later, I was still feeling ill and experiencing flu like symptoms, and I tested positive.
Fever, burning at injection site, hot, chills, fluctuating pulse and o2 levels: took Tylenol. 2/13 at 12 am
This spontaneous report was received from a male consumer of unknown age who on an unknown date was vaccinated with a dose of ZOSTAVAX (dose, route and lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The consumer reported that his arm still hurt at the injection site. No treatment information was reported. It was unspecified if the patient sought medical attention. The relatedness for arm still hurt at the injection site was unknown for ZOSTAVAX. Additional information has been requested.
Extreme pain at injection site, headache, nausea, dizziness, low grade fever and sweating, unable to lift or use arm without significant pain. Injection site hot to the touch. Could not participate in football practice the day of the injection. Unable to sleep the night of the injection. Tried but was unable to work the day following injection. Treated with Tylenol every 6 hrs and ice compress the first day. Treated with 800 mg ibuprofen and ice the second day. Treatments have not relieved symptoms at all yet.
Headache, Myalgia, Fever, NauseaVomiting, severe left arm pain Narrative:
Dizziness, fever, low blood sugar, elevated pulse, diarrhea, intense back pain
Received Flumist on 30 Oct 2007. Did not know she was pregnant.
Patient started with chest pain on 02/28/2021 and subsequently went to the hospital on 03/01/2021 and was diagnosed with a STEMI.
Information has been received from a physician concerning a 57 year old female patient with no pertinent medical history and with penicillin allergy, allergy to erythromycin and tetracycline who on 04-OCT-2010 was vaccinated with a dose of MMR II (Lot # 665427/0667Z) subcutaneously into her right arm "tricep". Concomitant therapy included PRAVACOL, BENICAR HCT and FLULAVAL which was given into her left arm on the same day. The physician reported that the patient developed "cellulitis" that required hospitalization. The physician reported that the patient developed pain, swelling and redness at the injection site on the right arm and a fever above 104 degrees F nine days after receiving MMR II. The physician could not provided a time line for the progression of the pain, swelling and redness at the injection site or the fever at the time of the report. There were unspecified "lab work up" performed in hospital. It was reported that the patient contacted the physician on 22-OCT-2010 from the hospital and reported being "slightly improved", but not recovered. Additional information has been requested.
Pain and swollen arm/shoulder right away, been to orthodontist, physical therapy and still can fully recover. I have pain when I move my left arm/shoulder, specially when getting dress or any movements going across and over my head.
swollen arm, feels like a knot underneath,  where vaccine was given with a red swollen spot and itchy. Feeling a bit fatigued and achy in back with some chills.
Patient felt pain and heaviness to right back side of head/neck area and reported dizziness. Patient states she has a history of vertigo and gets dizzy easily.
Third Shingrix dose given outside of recommended two shot series.   Patient came to pharmacy and discussed Shingrix with staff.  We did  search that showed incomplete history of one Shingrix.  In area due "no data available at this time".  Open ended question patient  confirmed 2nd Shingrix.  Asked to check on flu status.  Reran report and full history populated and discovered today patient was given third Shingrix dose.
4 days after immunization pt had headache, vertigo, nausea, chills, sweats, swollen glands, blurred vision  . Pt's records attached  .
Headaches, dizziness, neurological, having trouble seeing out of left eye, trouble remembering and forming sentencing
No adverse effects reported; Patient was vaccinated with a dose of improperly stored of GARDASIL and VAQTA; This spontaneous report was received from a medical assistant concerning to a patient of unknown age and gender. The patient medical history, concurrent conditions and concomitant medications were not reported.  On an unknown date, the patient was vaccinated with improperly stored HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot #R032766, expiration date on for prophylaxis (strength, dose and frequency were not reported) and Hepatitis A Vaccine, Inactivated (VAQTA) (S005724, exp: 07/10/2020; S007769, exp: 07/24/2020; R035227, exp: 01/01/2020) for prophylaxis (strength, dose and frequency were not reported). The temperature of storage and time frame of the excursion were above 47°F (92.3° F) for 13 hours 11 minutes and above 47°F (73°F) for 9 hours. There was a digital data logger involved, but there was no previous temperature excursion.   No adverse effect was reported.  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-1907USA007468: US-009507513-1907USA007439: US-009507513-1907USA005368: US-009507513-1907USA005362: US-009507513-1907USA010550: US-009507513-1907USA010551: US-009507513-1907USA010552: US-009507513-1907USA010553: US-009507513-1907USA010554: US-009507513-1907USA010555: US-009507513-1907USA010556: US-009507513-1907USA010558:
8/16/06 about 11:00 TD given. That evening began with chills and very sore deltoid. While working 11-7 sore neck, increasing chills, headache, 8/17 at 0500 felt like I had flu, like I was hit by a truck. Chest began to get sore hurt to breath. 1100 muscle cramps in legs. Fever 101.3F headache worse, blurred vision. Consulted family doctor. Went to ER. CXR, Labs, EKG WNL.
Intussusception occurred on Nov. 1 . Evaluated at ER with ultrasound and given enema. Resolved easily . Child doing well.
Arm began to itch within 15 minutes. Arm has been incredibly sore and painful to touch or move. Injection site is swelled, red, extremely itchy. Injection site is painful when touched
armpits hurting and painful, also down sides; I guess this would be swollen lymph nodes
Narrative: 12/03/2020 COVID swab, result: not detected COVID infection following COVID vaccine series 01/06, Pfizer, dose #1 01/27, Pfizer, dose #2 07/28 pt cc: cough, diarrhea, myalgias, exposure: COVID+wife 08/30, Pfizer, dose #3 08/06 COVID swab, result: detected 08/12/ SARS-COV-2 Variant Sequencing result: pending.
This spontaneous report was received from a Nurse Practitioner regarding a female patient of unknown age. No concomitant medication was reported. On 22-DEC-2015, the patient was vaccinated with GARDASIL dose and it has been over 1 year since she received the 1st dose of GARDASIL. No adverse event was reported. The outcome of the event was unknown. Additional information has been requested.
I called several times to the patient, but no one answered, so I am not sure if there any problem.
Patient got Pneumovax23 on 12/7/21 at around 8pm and contacted pharmacy 12/8/21 8:30pm to report side effects. On 12/8/21 patient felt weak at lunch and took 2 extra strength Tylenol (Acetaminophen 500mg). Then in the afternoon the patient felt worse with flu like symptoms and this evening felt warm with fever. Patient reports he checked his temperature and it was at 99.5F. Counseled patient on expected side effects of the vaccine and to take Tylenol which is preferred. Patient said they will take some more Tylenol this evening before bed.
Had a seizure that lasted an hour and 15 minutes. My blood pressure and heart rate have been unstable since the seizure.
Starting few hours after influenza vaccine, developed severe body aches, joint aches, headaches, chills, feverish, flushing/hot, shivering, diaphoresis. Reported 8/10 of pain. Woke up with contractions of hands/arms Monday night (had to stretch/move to relax). Reports tightness in chest and reported 'kidneys hurt' feeling as dehydrated. Reports constant symptoms for the next few days, slowly improving each day until resolution on Friday, 4 days later. Complete resolution.
Narrative: Patient developed a headache and nausea shortly after receiving their second dose of Pfizer covid vaccine. Patient required no additional intervention and was able to leave without issue.
facial twitches in hands and legs/facial twitch had her up all night; tremors in hands and legs / shaking; nervous/raw nerves; anxiety/anxious; facial contractions on left side of face; couldn't do 2 things at once / freezes if things come at same time; This spontaneous case was reported by a nurse and describes the occurrence of MUSCLE TWITCHING (facial twitches in hands and legs/facial twitch had her up all night), TREMOR (tremors in hands and legs / shaking), NERVOUSNESS (nervous/raw nerves), ANXIETY (anxiety/anxious) and FACIAL DISCOMFORT (facial contractions on left side of face) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.  Concomitant products included CLONAZEPAM (CLONOPIN), PREDNISONE and TOCILIZUMAB (ACTEMRA) for an unknown indication.  No medical history was reported by reporter.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCLE TWITCHING (facial twitches in hands and legs/facial twitch had her up all night), TREMOR (tremors in hands and legs / shaking), NERVOUSNESS (nervous/raw nerves), ANXIETY (anxiety/anxious), FACIAL DISCOMFORT (facial contractions on left side of face) and FEELING ABNORMAL (couldn't do 2 things at once / freezes if things come at same time). At the time of the report, MUSCLE TWITCHING (facial twitches in hands and legs/facial twitch had her up all night), TREMOR (tremors in hands and legs / shaking), NERVOUSNESS (nervous/raw nerves), ANXIETY (anxiety/anxious), FACIAL DISCOMFORT (facial contractions on left side of face) and FEELING ABNORMAL (couldn't do 2 things at once / freezes if things come at same time) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No treatment information was reported by reporter.
Information has been received from a licensed practical nurse referring to a patient of unknown age and gender. On 04-AUG-2016 a dose of improperly stored M-M-R II (lot# L032044, rHA, expiration date 24-AUG-2017) was given to the patient. No adverse effects reported. The temperature excursion was 48 degree Fahrenheit for 24 hours, data logger was used. There was no prior excursion. The temperature was back in range at the time of the reporting. This is one of several reports received from the same source. Additional information is not expected as there is no consent to contact the physician.
Information has been received from a licensed visiting nurse concerning a 35 year old male with diabetes and no allergies who on 01 Dec 2006 was vaccinated with a 0.65 mL dose of Zostavax (lot #652946/1012F). Concomitant therapy included Fortamet. On 01 Dec 2006, the patient felt an itch on his scalp and some body parts including his back, legs, and chest. There were no visible rashes. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. At the time of the report, the patient was recovering. A product quality complaint was not involved. Additional information has been requested.
The shoulder where the vaccine was administered was full blown; Hard under the rash; Rash at the injection site; Redness area of about 2 or 3 inches; Itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE JOINT EFFUSION (The shoulder where the vaccine was administered was full blown), VACCINATION SITE INDURATION (Hard under the rash), VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE ERYTHEMA (Redness area of about 2 or 3 inches) and VACCINATION SITE PRURITUS (Itching) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METOPROLOL and HYDROCORTISONE for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE JOINT EFFUSION (The shoulder where the vaccine was administered was full blown), VACCINATION SITE INDURATION (Hard under the rash), VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE ERYTHEMA (Redness area of about 2 or 3 inches) and VACCINATION SITE PRURITUS (Itching). At the time of the report, VACCINATION SITE JOINT EFFUSION (The shoulder where the vaccine was administered was full blown), VACCINATION SITE INDURATION (Hard under the rash), VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE ERYTHEMA (Redness area of about 2 or 3 inches) and VACCINATION SITE PRURITUS (Itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Cream
Soreness at injection site, muscle aches throughout body, headache, fatigue, mild nausea  Injection site less sore on the following day, other symptoms resolved.
This prospective pregnancy case was reported by a consumer and described the occurrence of diarrhea in a 38-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report during pregnancy. No previous pregnancies. On 9 November 2012 the subject received unspecified dose of FLUARIX (unknown). Her last menstrual period was on 27 May 2012 and estimated date of delivery was 03 March 2013. The subject reported she is having a C-section, date not yet scheduled. The pregnancy was by normal conception with no contraception. No evidence of a defect from prenatal testing. The subject was exposed to FLUARIX during the second trimester. On 09 November 2012, at the time of vaccination with FLUARIX, the subject experienced diarrhea, nausea, morning sickness and vaccine exposure during pregnancy. Within the same week, at an unspecified time after vaccination with FLUARIX, the subject experienced diarrhea, nausea, and morning sickness. The subject stated she has not had nausea or morning sickness with her pregnancy until she received FLUARIX. The symptoms were getting better; at the time of the report the diarrhea was mild. At the time of reporting the diarrhea, nausea, and morning sickness were improved. 06 May 2013 - No further information provided; patient lost to follow-up.